MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

drugmaker

  • Drugmaker Amgen Lays Off 300 US Employees
    Drugmaker Amgen Lays Off 300 US Employees
    Drugmaker Amgen Inc. said on Monday that it let go about 300 U.S. employees or about 1.2 percent of its total workforce, citing recent organizational changes to its commercial team. ...
    January 30, 2023BY Reuters
  • Endo Files for Bankruptcy as US Opioid Litigation Drags
    Endo Files for Bankruptcy as US Opioid Litigation Drags
    Endo International Plc. filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its ...
    August 17, 2022BY Reuters
  • Japan’s Shionogi Seeks Approval for COVID-19 Pill
    Japan’s Shionogi Seeks Approval for COVID-19 Pill
    TOKYO—Drugmaker Shionogi & Co. Ltd. has applied for approval to make and sell its oral COVID-19 treatment in ...
    February 26, 2022BY Reuters
  • Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
    Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
    NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
    January 27, 2022BY Reuters
  • Drugmaker Endo Signs $65 Million Opioid Settlement With Florida
    Drugmaker Endo Signs $65 Million Opioid Settlement With Florida
    Drugmaker Endo International plc said on Tuesday it had agreed to pay up to $65 million to resolve ...
    January 18, 2022BY Reuters
  • Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
    Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
    Shares of Biogen Inc fell nearly 10 percent on Wednesday after the U.S. government announced limited coverage of ...
    January 13, 2022BY Reuters
  • Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
    Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
    NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
    December 30, 2021BY Reuters
  • AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
    AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
    AstraZeneca will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker ...
    September 29, 2021BY Reuters
  • EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
    July 28, 2021BY Reuters
  • Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK
    Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK
    ZURICH—Roche is looking for another location to carry out trials of its pill to fight COVID-19, after plummeting ...
    April 21, 2021BY Reuters
  • EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
    EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
    BRUSSELS—Europe's fight to secure COVID-19 vaccine supplies intensified on Thursday when the European Union warned drug companies such ...
    January 28, 2021BY Reuters
  • Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment
    Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment
    NORMAN, Okla.—An Oklahoma judge on Aug. 26 found that Johnson & Johnson and its subsidiaries helped fuel the ...
    August 26, 2019BY The Associated Press
  • Allergan’s Bold Patent Move Could Transform Pharma Landscape
    Allergan’s Bold Patent Move Could Transform Pharma Landscape
    Pharmaceutical giant Allergan struck a bold and unusual deal to protect its patents on a lucrative eye drug ...
    November 11, 2017BY Fan Yu
  • Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
    Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
    Eli Lilly has dropped a lower-than-expected 2016 forecast on Wall Street after wrapping up a year in which ...
    January 5, 2016BY The Associated Press
TOP NEWS
  • Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
    2hr By T.J. Muscaro
    Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
  • Iran Launches First Missiles at Israel Since Ceasefire Agreement
    3hr By Jacki Thrapp
    Iran Launches First Missiles at Israel Since Ceasefire Agreement
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    4hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    4hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    6hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    7hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
    7hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    11hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    12hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
    18hr By Melanie Sun
    Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top